Monoclonal antibodies that distinguish non-small cell from small cell lung cancer

J. L. Mulshine, F. Cuttitta, M. Bibro, J. Fedorko, S. Fargion, C. Little, D. N. Carney, A. F. Gazdar, J. D. Minna

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Two murine IgG2Ak monoclonal antibodies (703D4, 704A1) were produced and characterized after immunization with a human large cell lung cancer line (NCI-H157). These antibodies detect different epitopes on 31 kilodalton [35S]methionine incorporating protein(s). Radiobinding and immunohistochemical studies show these antibodies bind to most (11/13) human non-small cell lung cancer (adenocarcinoma, epidermoid, and large cell), but not to small cell lung cancer (0/11) tumors tested. The epitopes these antibodies recognized are also expressed on human melanomas (7/8), two other tumors (osteogenic sarcoma, renal cell carcinoma), but not on many other human tumors (breast, colon, neuroblastoma, lymphoid), and not on a panel of normal adult human tissues. Because the antigen(s) are preserved after fixation and because of their ability to distinguish lung cancer types from each other and normal tissues, they should be of clinical, as well as of biologic interest.

Original languageEnglish (US)
Pages (from-to)497-502
Number of pages6
JournalJournal of Immunology
Volume131
Issue number1
StatePublished - 1983

Fingerprint

Small Cell Lung Carcinoma
Monoclonal Antibodies
Antibodies
Epitopes
Lung Neoplasms
Osteosarcoma
Neuroblastoma
Renal Cell Carcinoma
Non-Small Cell Lung Carcinoma
Methionine
Melanoma
Immunization
Neoplasms
Colon
Breast Neoplasms
Antigens
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Mulshine, J. L., Cuttitta, F., Bibro, M., Fedorko, J., Fargion, S., Little, C., ... Minna, J. D. (1983). Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. Journal of Immunology, 131(1), 497-502.

Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. / Mulshine, J. L.; Cuttitta, F.; Bibro, M.; Fedorko, J.; Fargion, S.; Little, C.; Carney, D. N.; Gazdar, A. F.; Minna, J. D.

In: Journal of Immunology, Vol. 131, No. 1, 1983, p. 497-502.

Research output: Contribution to journalArticle

Mulshine, JL, Cuttitta, F, Bibro, M, Fedorko, J, Fargion, S, Little, C, Carney, DN, Gazdar, AF & Minna, JD 1983, 'Monoclonal antibodies that distinguish non-small cell from small cell lung cancer', Journal of Immunology, vol. 131, no. 1, pp. 497-502.
Mulshine JL, Cuttitta F, Bibro M, Fedorko J, Fargion S, Little C et al. Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. Journal of Immunology. 1983;131(1):497-502.
Mulshine, J. L. ; Cuttitta, F. ; Bibro, M. ; Fedorko, J. ; Fargion, S. ; Little, C. ; Carney, D. N. ; Gazdar, A. F. ; Minna, J. D. / Monoclonal antibodies that distinguish non-small cell from small cell lung cancer. In: Journal of Immunology. 1983 ; Vol. 131, No. 1. pp. 497-502.
@article{997c1f259a4644f79aa1c023ec3939d4,
title = "Monoclonal antibodies that distinguish non-small cell from small cell lung cancer",
abstract = "Two murine IgG2Ak monoclonal antibodies (703D4, 704A1) were produced and characterized after immunization with a human large cell lung cancer line (NCI-H157). These antibodies detect different epitopes on 31 kilodalton [35S]methionine incorporating protein(s). Radiobinding and immunohistochemical studies show these antibodies bind to most (11/13) human non-small cell lung cancer (adenocarcinoma, epidermoid, and large cell), but not to small cell lung cancer (0/11) tumors tested. The epitopes these antibodies recognized are also expressed on human melanomas (7/8), two other tumors (osteogenic sarcoma, renal cell carcinoma), but not on many other human tumors (breast, colon, neuroblastoma, lymphoid), and not on a panel of normal adult human tissues. Because the antigen(s) are preserved after fixation and because of their ability to distinguish lung cancer types from each other and normal tissues, they should be of clinical, as well as of biologic interest.",
author = "Mulshine, {J. L.} and F. Cuttitta and M. Bibro and J. Fedorko and S. Fargion and C. Little and Carney, {D. N.} and Gazdar, {A. F.} and Minna, {J. D.}",
year = "1983",
language = "English (US)",
volume = "131",
pages = "497--502",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - Monoclonal antibodies that distinguish non-small cell from small cell lung cancer

AU - Mulshine, J. L.

AU - Cuttitta, F.

AU - Bibro, M.

AU - Fedorko, J.

AU - Fargion, S.

AU - Little, C.

AU - Carney, D. N.

AU - Gazdar, A. F.

AU - Minna, J. D.

PY - 1983

Y1 - 1983

N2 - Two murine IgG2Ak monoclonal antibodies (703D4, 704A1) were produced and characterized after immunization with a human large cell lung cancer line (NCI-H157). These antibodies detect different epitopes on 31 kilodalton [35S]methionine incorporating protein(s). Radiobinding and immunohistochemical studies show these antibodies bind to most (11/13) human non-small cell lung cancer (adenocarcinoma, epidermoid, and large cell), but not to small cell lung cancer (0/11) tumors tested. The epitopes these antibodies recognized are also expressed on human melanomas (7/8), two other tumors (osteogenic sarcoma, renal cell carcinoma), but not on many other human tumors (breast, colon, neuroblastoma, lymphoid), and not on a panel of normal adult human tissues. Because the antigen(s) are preserved after fixation and because of their ability to distinguish lung cancer types from each other and normal tissues, they should be of clinical, as well as of biologic interest.

AB - Two murine IgG2Ak monoclonal antibodies (703D4, 704A1) were produced and characterized after immunization with a human large cell lung cancer line (NCI-H157). These antibodies detect different epitopes on 31 kilodalton [35S]methionine incorporating protein(s). Radiobinding and immunohistochemical studies show these antibodies bind to most (11/13) human non-small cell lung cancer (adenocarcinoma, epidermoid, and large cell), but not to small cell lung cancer (0/11) tumors tested. The epitopes these antibodies recognized are also expressed on human melanomas (7/8), two other tumors (osteogenic sarcoma, renal cell carcinoma), but not on many other human tumors (breast, colon, neuroblastoma, lymphoid), and not on a panel of normal adult human tissues. Because the antigen(s) are preserved after fixation and because of their ability to distinguish lung cancer types from each other and normal tissues, they should be of clinical, as well as of biologic interest.

UR - http://www.scopus.com/inward/record.url?scp=0020563459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020563459&partnerID=8YFLogxK

M3 - Article

C2 - 6306102

AN - SCOPUS:0020563459

VL - 131

SP - 497

EP - 502

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -